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Carcinogenic Potential of Phthalic Acid
Esters and Related Compounds:
Structure-Activity Relationships
by William M. Kluwe*
Chronic toxicity and carcinogenicity studies of several phthalic acid esters (PAEs) and compounds con-
taining a2-ethylhexyl moiety were conducted in Fischer 344 rats and B6C3F1 (hybrid) mice. The compounds
studied were phthalic anhydride, di(2-ethylhexyl) phthalate, butyl benzyl phthalate, diallyl phthalate, di(2-
ethylhexyl) adipate, tris(2-ethylhexyl) phosphate, and 2-ethylhexyl sulfate (sodium salt). Estimated maxi-
mum tolerable doses and fractionally lower doses ofeach compound were administered to groups of50 male
and 50 female rats and mice for 2 years, followed by sacrifice, necropsy, and histopathological examination
of major organs and tissues. The low toxic potencies of most of the compounds allowed for relatively high
doses to be given during the chronic studies. In general, the toxic manifestations of the PAEs were closely
correlated with their ester substituents. Although many of the PAEs possessed some carcinogenic activity,
target sites for such effects weredissimilar, suggesting the absence ofacommon mode ofaction. In contrast,
all ofthe 2-ethylhexyl-containing compounds studied possessed some hepatocarcinogenic activity, indicating
that this moiety may have a propensity for causing hepatocarcinogenesis in mice, particularly those ofthe
female sex. The 2-ethylhexyl compound that caused the greatest hepatocarcinogenic response in mice, di(2-
ethylhexyl) phthalate, was also hepatocarcinogenic in rats. Similarly, those with a relatively greater effect
in female mice were also active in male mice. Thus, sex and species differences in 2-ethylhexyl-induced
hepatocarcinogenesis in rodents are probably quantitative rather than qualitative in nature.
Introduction
Thereis considerableinterest instructure-activity re-
lationships in toxicology and carcinogenesis research as
they relate to biochemical and pathophysiological mech-
anisms oftoxicant action. However, equally important is
therolethatsuch structuralcorrelates withtissueinjury
could play in predicting chronic toxic response for well-
defined classes ofchemicals. Recognizing the limitations
oftechnicaland financial resourcesintoxicitytestingand
the obvious need toestimate chemicalhazards in atimely
manner, elucidation of structure-activity correlates is a
potentially efficient method for predicting chemical tox-
icity.
Much ofthe concern over the chronic toxic potential of
PAEs was triggered by the report that di(2-ethylhexyl)
phthalate (DEHP), the most widely used of the PAE
plasticizers, was hepatocarcinogenic in rodents (1).
Through its chronic toxicity and carcinogenicity studies
in rodents, the National Toxicology Program (NTP) has
conducted prechronic and chronic studies in male and
female rats and mice ofthree esters ofphthalic acid and
the anhydride form of phthalic acid, phthalic anhydride.
Careful comparisons of these results may indicate
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whether or not the phthalate moiety per se produces a
characteristic toxic response. Because ofthe large num-
ber ofphthalates used for commercial purposes (2), their
high volume ofproduction (3), and theirubiquitous pres-
ence in the environment (4) and human tissues (5), an
ability to predict toxic potential for phthalic acid esters
(PAEs) that have not yet been adequately tested would
be advantageous.
The NTP has also conducted prechronic and chronic
studies in rodents of three nonphthalate chemicals con-
taining a 2-ethylhexyl moiety, in addition to the 2-ethyl-
hexyl-containingphthalate, DEHP. Comparisons ofthese
data may suggest whether or not the 2-ethylhexyl group
is important in the expression of carcinogenic potential,
and whetherthe presence ofsuch amoiety would suggest
a potential for causing cancer.
The chemicals studied were phthalic anhydride (PAn),
butyl benzyl phthalate (BBP), diallyl phthalate (DAP),
di(2-ethylhexyl) phthalate (DEHP), di(2-ethylhexyl) adi-
pate (DEHA), tris(2-ethylhexyl) phosphate (TEHP) and
2-ethylhexyl sulfate (EHS). The structures of these
chemicals are shown in Figure 1.
DEHP is the plasticizer most commonly used for vinyl
products (8), comprising up to 50% (by weight) of some
plastic materials. DEHA is also used as a plasticizer,
particularly in food product containers where otherplas-
ticizers would be leached into fatty foods (9). BBP and2W M. KLUWE
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DAP are also used as plasticizers, the former for vinyl
products such as flooring and the latterin electrical com-
ponents. PAn is aprecursorinthe manufacture ofPAEs.
It is condensed with the appropriate alcohols to produce
the desired PAEs (e.g., PAn + 2-ethylhexanol forms
DEHP) (2). EHS is a surfactant used in food processing
andtextilemanufacture (10,11), whileTEHPisusedboth
as a plasticizer and as a flame retardant (12).
The data in each of these studies were individually
peer-reviewed and approved by a board ofindependent,
nongovernment scientists. More detailed data on each of
the individual studies can be obtained fromthe technical
report series (9,13-19).
Methods
Animals
Weanling rats of the inbred Fischer 344 strain and
weanling hybrid B6C3F1 mice were evaluated clinically
for 10to 14daysbefore thestarts ofthe studiesto ensure
the absence of parasites or disease. The animals were
housed throughout the studies in polycarbonate cages
containing hardwood bedding, 5 animals of a single sex
per cage. Rooms were controlled for temperature 21 +
20C), humidity (50 ± 20%) and light-cycle (12 hr flu-
orescent light; 12 hr dark). Food and water were freely
available.
Chemicals
PAn (> 98% pure) was obtained from Koppers Co.
(Pittsburgh, PA), BBP (> 98% pure) from Missouri Sol-
vents and Chemicals (Kansas City, MO), DAP (> 99%
pure) from Hardwicke Chemical Co. (Elgin, SC), DEHP
(> 99.5% pure) and DEHA (> 98% pure) from W.R.
Grace and Co. (Fbrds, NJ), and TEHP (> 98% pure)
from the United States Army Chemical Systems Labo-
ratory (Aberdeen, MD). EHS was obtained as a 40%
aqueous solution (38.8% EHS, 0.7% 2-ethylhexanol,
55.1% water) from Alcolac Inc. (Baltimore, MD).
PAn, BBP, DEHP, DEHA, or EHS were each mixed
directlyintothefeed, while DAP and TEHP weremixed
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with corn oil and administered by gavage. Gavage solu-
tions and feed were analyzed periodically to ensure ap-
propriate dosing.
Experimental Design
Animals certified healthy were assigned to cages, and
the cages were then assigned to treatment groups, using
tables ofrandom numbers. Groups of 10 animals ofeach
species and sex per dose were exposed to each (generally
five) chemical dose and vehicle or untreated control (ve-
hicle for gavage studies; untreated for feed studies) for
aperiod of13 weeks. Chemical-containing food was avail-
able throughout the studies, while gavage treatments
were administered once daily, 5 days/week. All animals
that died on test or were sacrificed in a moribund con-
dition, and survivors at the end of the 13 weeks were
givenacompletenecropsy. Majororgansfromthecontrols
and highest dose were examined histologically for chem-
ically induced morphological changes. Specific target tis-
sues were examined histologically in lower dose groups
to reach a no-observed effect level.
Estimated maximum tolerable doses (the highest
doses estimated not to reduce lifespan from other than
carcinogenic effects) for the chronic studies were deter-
mined from the prechronic (13 week) data and used as
the higher doses in the chronic studies. Groups of 50
animals of each species and sex were exposed for two
years (- 104 weeks) to one of two chemical doses or
control (the PAn control group consisted of only 20 ani-
mals/sex/species; all other studies contained 50 control
animals/sex/species). All animals that died on test or
were sacrificed in a moribund condition, and those killed
at termination were given a complete necropsy. Histolog-
ical examinations were performed on the major organs
of all animals. Both neoplastic and nonneoplastic lesions
were recorded.
Tumor occurrence data were analyzed both for dose-
related trends and for pairwise comparison of treated
groups with controls by three alternate methods: life-
table analysis (most appropriate for fatal tumors), inci-
dental tumor test (most appropriate for nonfatal tumors
observed at necropsy), and Fisher's exact test and Coch-
ran-Armitage trend test (based on the overall propor-
tions of tumor-bearing animals) (20,21). Survival prob-
abilities in the chronic studies were estimated by the
product-limit procedure (22), and analyzed for chemical
effects by the methods of Cox (23) and Tarone (24).
Results
Prechronic Studies
Dose ranges for the 13-week studies were as follows:
BBP, 1600-25,000 ppm; DAP, 25-400 mg/kg; PAn, 6200-
50,000 ppm; DEHP, 1600-25,000 ppm for rats, 800-
12,500 ppm for mice; DEHA, 1600-25,000 ppm; TEHP,
250-4000mg/kgforrats, 500-8000mg/kgformice; EHS,
10,000-40,000 ppm. In general, the highest doses used
in the subchronic studies caused mild-moderate retar-
dations of body weight gain. Compound-related deaths
in these studies occurred only at the 400 mg/kg dose of
DAP in male rats. DAP also caused hepatocellular ne-
crosis and hepatic fibrosis or cirrhosis in both sexes of
rats at 200 and 400 mg/kg; no liver lesions were observed
in the DAP-treated mice. Testicular atrophy was ob-
served in rats receiving the higher doses of BBP or
DEHP This lesion was characterized by a loss of the
germinating epithelium ofthe seminiferous tubules; Ser-
toli cells and interstitium appeared to be unaffected. No
lesions were observed in rats receiving PAn, DEHA,
TEHP, or EHS, and no lesions were observed in mice
receiving any of the seven compounds. Based on these
data, the doses shown in Table 1 were chosen for the
chronic studies. The two doses chosen per chemical, sep-
arated by a factor of two, will hereafter be referred to
as the "higher" and the "lower" doses.
Chronic Studies: Survival
With the exception of BBP and, possibly DEHP, the
chemical treatments did not clearly reduce survival in
the chronic studies. Survival of the lower dose DEHP
female mice only (not the higher dose) was significantly
less than that in the controls. This single statistically
significant survival difference in eight comparisons (two
species, two sexes, two doses), occurring as it did only
in the lower dose group and in the absence oflife-threat-
ening toxic lesions, was considered consistent with a
chance occurrence and not a chemical effect. In contrast,
male rats at both doses of BBP began to die after
- 15
weeks oftreatment and were all terminated at 30 weeks
due to poor group survival. Although no degenerative
lesions were observed histologically in the BBP-treated
male rats, internal hemorrhaging appeared to have oc-
curred as evidenced by the observance of clotted blood
at necropsy.
Chronic Studies: Neoplasia
Increased occurrence oftumors were not observed for
either sex or species of animal in the PAn study, or for
BBP-treated mice or DEHA-treated rats. One each of
the lower dose male and female mice and two each ofthe
higher dose male and female mice in the DAP study ex-
hibited papillomas ofthe forestomach. (DAP also caused
gastric hyperplasia and chronic gastric inflammation in
the mice.)
BBP increased the occurrence ofmononuclear cell leu-
kemia, a common tumor in aged Fischer 344 rats, in the
higher dose female rats (Table 2). DAP treatment was
related to an increased occurrence ofthis same tumor in
female rats, as well as with an equivocal increase in the
occurrence oflymphomas in male mice (Table 2).
DEHP increased the occurrences ofhepatocellular tu-
mors in both male and female rats and mice (Table 3).
This hepatocarcinogenic effect was evident in the higher
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Table 1. Doses used for the chronic studies.
Dose
Compound
Phthalic anhydride
Diallyl phthalate
Butyl benzyl phthalate
Di(2-ethylhexyl) phthalate
Di(2-ethylhexyl) adipate
Tris(2-ethylhexyl) phosphate
2-Ethylhexyl sulfate (Na+)
aU, untreated; V, vehicle.
dose male rats and in both the lower and higher dose
female rats and male and female mice. DEHP appeared
to increase the occurrence of both those neoplasms ca-
tegorized as carcinomas (malignant) and those charac-
terized as adenomas or neoplastic nodules (benign).
Except for DEHP, none of the seven chemicals in-
creased the occurrence ofliver tumors in rats. However,
the other three chemicals with a 2-ethylhexyl moiety ex-
hibited varyingdegrees ofhepatocarcinogenic activityin
mice, ranging from clear causal effect (DEHA) to equiv-
ocal causal effect (EHS). As shown in Table 4, DEHA
increased the occurrence oflivertumorsinbothmale and
female mice (although the response was stronger in fe-
males), and TEHP caused a small but significant (p <
0.05, p < 0.01) increase in hepatocellular carcinomas in
female mice, while EHS equivocally increased hepato-
cellular tumors in female mice only. As with DEHP, the
increases appeared to occur in both carcinomas and ad-
enomas, although somewhat more strongly in the former.
Chronic Studies: Nonneoplastic Lesions.
Nonneoplastic, chemically induced lesions were not ob-
served in animals treated chronically with PAn, BBP
(excluding male rats), DEHA or TEHP Dose-dependent
necrosis and fibrosis of the liver, periportal in distribu-
tion, and severe bile duct hyperplasia were observed in
DAP-treated rats. DAP-treatedmicedidnotdevelopliver
lesions, but gastric inflammation and hyperplasia were
evident. EHS also caused papillary hyperplasia of the
forestomach in male and female mice. Chronic inflam-
mation of the kidney was observed in the higher dose
male DEHP mice, and EHS appeared to be nephrotoxic
to rats in the chronic study, causing focal calcification
(males and females) and chronic inflammation (males
only). Inaddition, a rarerenaltubularadenomaoccurred
in a female rat at the higher dose of EHS, and rare
tumors of the renal pelvis occurred in one each of the
higher dose EHS male and female rats.
Table 2. Effects ofdially phthalate (DAP) or butyl benzyl phthalate (BBP) on the occurrence ofhematopoietic system tumors.
Overall incidence (%) and level of statistical significanceb
Compound Species Sex Tumora Control Lower dose Higher dose
BBP Rat Female Leukemia 7/49 (14%) 7/49 (14%) 18/50 (36%)
(MNC) p <0.01 p 0.01
DAP Rat Female Leukemia 15/50 (30%) 15/43 (35%) 25/49 (51%)
(MNC) p <0.05 p<0.05
Mouse Male Lymphoma 6/50 (12%) 5/50 (10%) 12/50 (24%)
p<0.05 p 0.05
aMNC, mononuclearcell (leukemia type).
bValues from the trend test are listed below the control group incidences, while values from pairwise comparisons are listed below the
treated group incidences. Only those values where both survival-adjusted tests (life table and incidental tumor tests) indicated p -0.05 are
shown. Historical incidences incontrolanimals (x ± SD;N>1000femalerats, 650malemice):leukemias, 16.1 ± 8.9%infemalerats;lymphomas,
10.7 ± 6.4% in male mice. These data are derived from 14 independent studies in mice and 23 independent studies in rats.
Species
Rat
Mouse
Rat
Mouse
Rat
Mouse
Rat
Mouse
Rat
Mouse
Rat
Mouse
Rat
Mouse
Sex
M, F
M
F
M, F
M, F
F
M, F
M, F
M, F
M, F
M, F
M
F
M, F
M
M
F
Controla
U
U
U
V
V
U
U
U
U
U
U
V
V
V
U
U
U
Lower
7,500 ppm
16,000 ppm
12,000 ppm
50 mg/kg
150 mg/kg
6,000 ppm
6,000 ppm
6,000 ppm
3,000 ppm
12,000 ppm
12.000 ppm
2,000 mg/kg
1,000 mg/kg
500 mg/kg
10,000 ppm
5,000 ppm
10,000 ppm
Higher
15,000 ppm
33,000 ppm
24,000 ppm
100 mg/kg
300 mg/kg
12,000 ppm
12,000 ppm
12,000 ppm
6,000 ppm
25,000 ppm
25,000 ppm
4,000 mg/kg
2,000 mg/kg
1,000 mg/kg
20,000 ppm
10,000 ppm
20,000 ppm
274CARCINOGENIC POTENTIAL OF PHTHALIC ACID ESTERS
Table 3. Effects ofdi(2-ethylhexyl) phthalate on the occurrences of hepatocellular tumors.
Overall incidence (%) and level of statistical significancea
Species Sex Type ofhepatocellular tumor Control Lower dose Higher dose Historical controlsb
Rat Male All (combined)c 3/50 (6%) 6/49 (12%) 12/49 (24%) 4.2 + 3.9%
p<0.1 p<0.05
Carcinoma 1/50 (2%) 1/49 (2%) 5/49 (10%) 0.8 + 1.1%
p<0.05
Female All (combined)c 0/50 (0%) 6/49 (12%) 13/50 (26%) 3.1 ± 3.2%
p<0.001 p<0.05 p<0.001
Carcinoma 0/50 (0%) 2/49 (4%) 8/50 (16%) 0.2 ± 0.7%
p<0.005 p<0.01
Mouse Male All (combined)d 14/50 (28%) 25/48 (52%) 29/50 (58%) 31.1 ± 7.5%
p <0.01 p <0.05 p<0.01
Carcinoma 9/50 (18%) 14/48 (29%) 19/50 (38%) 21.3 ± 6.9%
p<0.05 p<0.05
Female All (combined)d 1/50 (2%) 12/50 (24%) 18/50 (36%) 7.9 ± 4.6%
p <0.0001 p <0.001 p<0.0001
Carcinoma 0/50 (0%) 7/50 (14%) 17/50 (34%) 4.1 ± 3.0%
p <0.0001 p <0.01 p<0.0001
aValues from the trend test are listed below the control group incidences, while values for pairwise comparisons are listed below the treated
group incidences. Only those values where both survival-adjusted tests (Life Table and Incidental Tumor Tests) indicated p<0.05 are shown.
bIncidences forhistorical controls are given as x ± SD, N>2000rats, 1000 mice ofeach sex. (These data are based on 22 independent studies
in mice and 42 independent studies in rats.)
cCombined = hepatocellular carcinomas or neoplastic nodules.
dCombined = hepatocellular carcinomas or adenomas.
Discussion
Comparative evaluation ofseveral studiesusing a com-
mon protocol allows for limited conclusions to be drawn
about the relationship of molecular structure to the bi-
ological activity of the subject chemicals. The generally
low order of acute toxic potency of the phthalate esters
(and the 2-ethylhexyl compounds tested) led to the use
ofrelatively high doses for the chronic studies, thus in-
creasing the probability ofdetecting toxic effects should
such occur. Despite the large doses, little nonneoplastic
toxicity or survival reduction occurred, reinforcing the
adequacy ofthese studies for carcinogenicity evaluation.
Several potential target sites for carcinogenic activity
of phthalates were found, including liver (DEHP), he-
matopoietic system (BBP, DAP) and forestomach (DAP).
However, these sites were generally affected by only one
ofthe PAEs, and the increased tumor occurrences were
Table 4. Effects ofdi(2-ethylhexyl) adipate (DEHA), tris(2-ethylhexyl) phosphate (TEHP), or 2-ethylhexyl sulfate (EHS) on the
occurrences of hepatocellular tumors in mice.
Overall incidence (%) and level of statistical significance'
Compound Sex Type ofhepatocellular tumor Control Lower dose Higher dose
DEHA Male All (combined) 13/50 (26%) 20/49 (41%) 27/49 (55%)
p<0.01 p<0.01
Carcinoma 7/50 (14%) 12/49 (24%) 12/49 (24%)
Female All (combined) 3/50 (6%) 19/50 (38%) 18/49 (37%)
p <0.001 p <0.001 p<0.001
Carcinoma 1/50 (2%) 14/50 (28%) 12/49 (24%)
p<0.01 p <0.001 p <0.005
TEHP Male All (combined) 15/50 (30%) 21/50 (42%) 18/49 (37%)
Carcinoma 9/50 (18%) 12/50 (24%) 12/50 (24%)
Female All (combined) 2/48 (4%) 8/50 (16%) 10/50 (20%)
p<0.05 p<0.05
Carcinoma 0/48 (0%) 4/50 (8%) 7/50 (14%)
p <0.01 p <0.05
EHS Male All (combined) 10/50 (22%) 8/45 (18%) 8/44 (18%)
Carcinoma 8/45 (18%) 8/45 (18%) 6/44 (14%)
Female All (combined) 1/45 (2%) 3/46 (7%) 6/45 (13%)
p<0.05 p=0.05
Carcinoma 0/45 (0%) 1/46 (2%) 3/45 (7%)
p=0.05 p=0.05
aSee Table 3 for historical incidences.
2752W M. KLUWE
generally restricted to one sex and species. Therefore,
the comparative data do not suggest that PAEs per se,
or the phthalate moiety, possess innate carcinogenic po-
tential.
In contrast, all four chemicals with a 2-ethylhexyl
group (DEHP, DEHA, TEHP, EHS) exhibited some evi-
dence ofhepatocarcinogenic potential inrodents, ranging
from very strong (DEHP) to equivocal (EHS). The data
for these compounds are compared in Table 5, wherein
thelevelofstatisticalsignificance ofincreased livertumor
incidence is used as a rough estimate of the degree of
hepatocarcinogenic effect (ignoring molar differences in
dose).
The data in Table 5 indicate a greater relative suscep-
tibility of mice than rats, and of females than males to
the hepatocarcinogenic activity of the 2-ethylhexyl-con-
taining chemicals. The reason(s) for such differences is
unknown. Although liver tumors occur with a higher
spontaneous frequency in B6C3F1 mice than in Fischer
344 rats, the male B6C3F1 mice, which have a much
higher spontaneous liver tumor rate than do the females
of this strain (31% vs. 8%), were less susceptible than
the females. Thus, the apparent species and sex differ-
ences in response to DEHP, DEHA, TEHP, or EHS are
not easily equated with spontaneous liver tumor fre-
quencies. DEHPtreatmenthasbeenreportedtopromote
growth and malignant transformation of diethylnitrosa-
mine-induced hepatocellular foci in B6C3F1 mice (25),
but another laboratory has indicated a lack of such ac-
tivity for DEHP in Fischer 344 rats (J. Popp, Chemical
Industry Institute of Toxicology, personal communica-
tion). Such species differences in the promotional capa-
bilitiesofDEHPtowardsdiethylnitrosamine-induced he-
patoceilular foci, despite hepatocarcinogenic activity in
both test species, suggest the possibility of species dif-
ferences in the mechanisms of DEHP-stimulated tumor
formation. Since those compounds with the strongest ac-
tivity in female mice (DEHP, DEHA) were also effective
in male mice, and the strongest carcinogen (strength of
evidence) in mice (DEHP) was also carcinogenic in rats,
these sex and species differences in response would ap-
pear to be of a quantitative rather than of a qualitative
nature.
The four 2-ethylhexyl-containing compounds, despite
their shared moiety, differ in chemical and physical char-
acteristics. DEHP and DEHA are lipophilic plasticizers,
EHS is a water-soluble anionic surfactant (detergent),
while TEHP is a phosphate flame retardant with plas-
ticizing properties. Both DEHP and DEHA are known
to be rapidly metabolized to 2-ethylhexanol and their
corresponding monoesters in the gut (26,27). Some 2-
ethylhexanol is also likely on structural grounds to be
released from TEHP in vivo, although confirming data
are not available. Most of an oral dose of EHS was re-
portedly excreted in an unchanged form, but some (-
28%) was converted to 2-ethylhexanol and 2-ethylhexyl
metabolites (28). Thus, all four compounds are probably
metabolized to 2-ethylhexanol, and the rank order of 2-
ethylhexanol generation would be DEHP, DEHA >>
EHS (TEHP unknown). Therefore, it would be tempting
to conclude that the released 2-ethylhexanol is respon-
sible for the hepatocarcinogenic effect, but insufficient
data are available to confirm or refute such speculation.
The PAEs and the 2-ethylhexyl-containing compounds
compared in this communication have been found to lack
mutagenic activity in Salmonella typhimurium testing
strains (14,15,29-31; also E. Zeiger, National Toxicology
Program, personal communication). While some chro-
mosomal changes have been reported to be induced by
DEHP or the monoeasters mono(2-ethylhexyl) phthalate
or mono(2-ethylhexyl) adipate in vitro (32), such effects
havenotbeenconfirmed invivo. Analternatemechanism
ofhepatocarcinogenic action forthe 2-ethylhexyl-contain-
ing compounds may be via peroxisome proliferation.
Reddy and co-workers, based on a positive correlation
betweenthe abilitiesofseveralchemicalsto causehepatic
peroxisome proliferation and to produce liver tumors in
animals, haveproposed peroxisome proliferators as adis-
tinct class ofchemical carcinogens (33-35). Treatment of
rats or mice with DEHP, DEHA, 2-ethylhexanol or 2-
ethylhexanoic acid (a metabolite of 2-ethylhexanol),
caused hepatic peroxisome proliferation, while structur-
ally similar compounds lacking a 2-ethylhexyl group
(e.g., adipic acid, hexanol) did not (36). DEHP-induced
peroxisomes contained much higher specific activities of
H202-generating oxidases than did normal peroxisomes,
Table 5. Comparative effects ofcompounds with a 2-ethylhexyl moiety on the occurrences of hepatocellular tumors in rats and mice.'
Rats Mice
Male Female Male Female
Lower Higher Lower Higher Lower Higher Lower Higher
Type ofhepatocellular tumor Test compound dose dose dose dose dose dose dose dose
All (combined)b DEHP - + + + + + + + + + + + + + + +
DEHA - - - - - + + +++ + + +
TEHP - - - - - - - +
2EHS - - - -+
Carcinomas DEHP - + - ++ - + + + + + + +
DEHA - - - - - - + + + + +
TEHP - - - - - - - +
2EHS - - - - - - - -
aLegend (level of statistical significance): -, p > 0.05; ±, p = 0.05; +, 0.01 <p <0.05; + +, 0.001 <p <0.01; +++, 0.0001 <p <0.001;
+ + + +, p <0.0001.
bCombined = Hepatocellular carcinomas or adenomas (mice) or neoplastic nodules (rats).
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but nearly the same activity as the H202-detoxifying
exzyme catalase (36). More recently, Melnick and co-
workers have demonstrated an increased steady state
level of H202 in liver homogenates from DEHP-treated
rats (37). Whether or not such an increased capability of
peroxisomal generation of H202 could upset cellular ox-
ygen metabolism and lead to cellular damage via exces-
sive generation of reactive oxygen species is at present
unknown. There is no data available to indicate whether
or not TEHP or EHS induce hepatic peroxisomes in ro-
dents, butmetabolicrelease of2-ethylhexanol fromthese
compounds would be expected to do so.
The nonneoplastic effects of the PAEs seem to be
closely related to metabolism to the monoesters and the
alcohols. Both BBPand DEHPcaused testicularatrophy,
effects that can be reproduced by phthalate mono-
esters with linear alkyl chain lengths of approximately
3-7 (38-40). Recent studies have shown that BBP is ex-
tensivelymetabolized inratstomonobutylphthalate (41).
Similarly, ratsextensivelymetabolizeDAPtoallylalcohol
and acrolein, and the hepatotoxic effects of DAP in rats
(periportalhepatocellularnecrosis, fibrosisandcirrhosis)
areconsistentwiththose ofallylalcohol and acrolein (19).
Mice are better able to detoxify the allyl alcohol product
ofDAP and do not manifest with a hepatotoxic response
(19).
In conclusion, comparative evaluations ofchronic toxic
response to several PAEs did not reveal common neo-
plastic or nonneoplastic lesions suggestive of structural
correlates of toxic activity. However, the 2-ethylhexyl
group appeared to be related to hepatocarcinogenic ac-
tivity in rodents, particularly in female mice. The major
objectives of chronic animal carcinogenicity studies are
to detect chemicals with oncogenic activity in experi-
mentalanimalsandtoestimatethehazardsofsuchchem-
icals to man. The limitations ofthis type ofstudy include
the required use ofrelatively high doses (generally much
higherthananticipatedhumanexposure), surrogatespe-
cies (generally rodents) and subjective criteria oftumor-
igenicactivity Suchanimaldataareofirreplaceablevalue
in predicting toxic effects (or lack thereof) in humans,
but additional studies are needed to confirm or refute
thevalidity ofextrapolation fromtheresponse ofrodents
to the response ofhumans. In particular, more study is
needed on the speculated causal relationship between
peroxisomes and neoplasia, and of DEHP-induced per-
oxisomes to DEHP-induced hepatocellular tumors. This
typeofinformation, alongwiththerecentdataonspecies
differences in chemically induced peroxisomal prolifera-
tion (42,43), will strengthen confidence in our ability to
predict the hazards of DEHP, 2-ethylhexyl-containing
compounds, and peroxisome proliferators in general to
human health.
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